CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that Robert Bazemore, President and Chief Executive Officer, will participate in a fireside chat during the Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 2:30 p.m. ET. A live webcast of the fireside chat will be available in the investor section of the Company's website at www.epizym
Full ArticleEpizyme to Participate in Jefferies Virtual Healthcare Conference
Business Wire
0 shares
1 views